The Eradigm team is made up of a group of highly motivated, experienced professional consultants who come from a diverse range of backgrounds. Our vast collective experience spans all aspects of pharma, biotech and life sciences and has been gained addressing the most complex strategic challenges for the most demanding of organisations. Each of our client teams are led by a senior consultant, with a partner involved on every brief that we address.
Partners and Directors
With a career in consulting spanning almost 15 years, Patrick cares deeply about helping clients crystallise complex multi-component strategic challenges at all stages of the product and company lifecycle. His clients include multinational manufacturers of cutting-edge and mature biopharmaceuticals, vaccines and medical technologies. Patrick is inquisitive and thought provoking, leveraging his broad experience to help drive smarter, more holistic strategies tapping into subtle sources of competitive advantage. His work cuts across and unites internal functional areas, building consensus within organizations around the business case for transformational initiatives, developing and communicating the evidence architecture for diverse teams to take bold decisions with confidence.
As a founding partner of Eradigm, Patrick plays a critical role in shaping the culture of the business, working closely within the team to cultivate a passion for unparalleled excellence, and a learning environment in which consultants can push themselves towards being among the biopharmaceutical industry’s very best strategic minds. He is passionate about nurturing raw, world class consulting talent. Patrick is a visiting lecturer on various graduate programmes spanning Innovation, Entrepreneurship and Biopharma Business Strategy at the University of Cambridge and at Imperial College London.
Prior to founding Eradigm, Patrick spent the best part of a decade building a global strategy consultancy. In a former life, he was a globetrotting biochemist, latterly working at the University of California Berkeley, and the Tokyo Institute of Technology. He holds a BSc. in Biology from the University of Bristol, a Masters from the University of York and a PhD from the University of Sheffield. A keen linguist, Patrick speaks fluent French, Italian and Izakaya level Japanese.
Patrick spends his personal time with his wife and three young children, bouncing around the South East of the UK coordinating tennis, swimming, climbing, piano, ballet and numerous other after school activities. When he has a few seconds to himself, he can be found at his local triathlon club, churning out the meters in the pool or reservoir, or pounding the footpaths of the British countryside on long distance runs. Patrick has completed multiple marathons and ultramarathons and one day once the kids have fled the nest, will aim to traverse Asia on his adventure motorbike and explore every gastronomic corner of Italy.
Learn more about Patrick and the journey to Eradigm
The EMG GOLD Podcast aims to provoke conversations with stakeholders in the pharmaceutical industry, reports on the latest trends and innovations, and shares insight from high-profile guests. In this 2020 Podcast, Patrick Romano provided more insights into his career to date and how this shaped his thinking around Eradigm’s offering.
https://www.emg-health.com/omnipresent/?category=podcasts/
Marcus is respected for taking a no-nonsense approach throughout his 20 years in life sciences. With experience in the trenches of strategic marketing, market access, product launch and competitive strategy, Marcus can see the wood from the trees – which is often half the battle in our increasingly complex stakeholder environment.
When technology is poised to make material differences to the very value proposition that pharmaceutical companies offer, when new themes are emerging from preventative care to consumerisation to digital drug design, only a handful people are able to cut through the hype and establish what is important. Marcus’ brand of thoughtful yet straightforward leadership is what clients and colleagues rely on to see through to the other side – and understand where resources should be invested today.
Marcus was previously Principal at Deallus Consulting, Global Vice President at Voisin Consulting and European Vice President at GfK Bridgehead. In these positions he built multiple expert teams of consultants providing market insights, launch readiness and lifecycle management support for global biopharmaceutical clients. He also played a key role in helping Deallus redefine their company growth strategy after a private equity acquisition.
Prior to that he had a number of global roles in market access, launch strategy, marketing and brand management at companies including Novartis, Eisai and Takeda. In every instance, he was able to harmonise and refocus teams around what really mattered for better performance.
As co-founding partner of Eradigm, Marcus’ simple philosophy, which he ensures is ingrained within the fabric of Eradigm, is ‘consult first, strive for excellence and deliver uncomplicated quality’.
Marcus spends his personal time with his family, generally trying (and failing) to avoid being a taxi-service for his 2 children (football, rugby, piano, swimming etc etc….) and attempts to live his life by 3 simple rules: 1. Make time. 2. Read more and scroll less and 3. If you don’t like something, change it. If you can’t change it, change your attitude…
Javier rejoined Eradigm as a Director in April 2025, with a longstanding career across both Competitive Intelligence and Strategy consulting.
Prior to his return, he had been part of the senior leadership teams at IPG Health Consulting and Vintura; boutique Life Sciences consultancies where he led the UK consulting business, championed the early commercialisation value proposition and delivered work across competitive strategy, commercial strategy, and market access with Big Pharma and Biotechs in both the US and EU.
Before this, Javier was a core member of the Eradigm’s growth for over 3 years and brings a prior foundation in both Biochemical Engineering (MEng) and management consulting at PA Consulting.
He has worked across a number of therapeutic areas, with particular focus in rare diseases, oncology & haematology, immunology and novel platforms such as cell & gene therapies and AI.
Outside of work he is an avid traveller, having just completed a world tour to over 20 countries, and a keen musical theatre enthusiast, for which being based in central London has certainly paid off.
David rejoined Eradigm as a Director in April 2025, building on his earlier contributions since 2020 as a key driver of the firm’s delivery excellence.
He holds a PhD in DNA Repair and Radiotherapy from the Institute of Cancer Research, where his research focused on uncovering the molecular drivers of fraction size sensitivity. He also earned an MSci in Genetics from University College London, specialising in the biology of ageing. David brings deep scientific expertise across oncology, infectious diseases, and immunology.
David is known for his strategic clarity and ability to guide clients through complex decision-making, delivering measurable impact across global projects. With a strong foundation in competitive intelligence (CI) methodologies, he designs and leads projects that effectively bridge CI and strategy. His insights are shaped by extensive industry experience across all levels—from individual products to cross-portfolio and corporate strategy—enhanced by a solid grounding in market access.
David’s approach to leadership and mentorship is defined by analytical rigour, curiosity, and a collaborative spirit that aligns with Eradigm’s ethos.
Outside of work, David is a passionate athlete, competing internationally in Canoe Polo, a fast-paced five-a-side kayaking sport. He also enjoys combining his love of travel and conservation through amateur wildlife photography.
Focus areas
All financial aspects of Eradigm. Among other things, this includes ensuring appropriate controls and processes are in place to enable the business to function effectively, business planning and analysis to support decision-making and leading the Eradigm Finance Team. I provide strategic guidance, insight and reassurance to the Eradigm Leadership Team.
Specialist expertise
I’m a qualified accountant and a member of the Association of Chartered Certified Accountants. My background is very commercial, so I’m experienced in planning and analysis, forecasting, budgeting and management reporting and cashflow reporting and management. I also have extensive experience in dealing with technical accounting matters, including statutory reporting and audit.
Education
Bachelor’s Degree in Accounting and Finance from the University of Brighton. ACCA qualified accountant.
What is your focus at Eradigm?
Ensuring that all financial aspects of the business are managed effectively. This includes providing clear information for decision-making in a way which can be readily understood by both financial and non-financial users. I see my role as making sure that “everything is working as it should” and providing recommendations, support and guidance on potential areas for improvement.
I also ensure that all finance-related statutory requirements are met, including annual accounts, tax compliance and audit.
Who do you work with?
The Finance Team is an integral part of the Eradigm business – we support, analyse and challenge across all areas where we feel we can make a positive impact.
My primary contacts are the Partners and Senior Management Team – providing them with relevant financial insights and recommendations to help the business to be as successful as possible.
What did you do before Eradigm?
My career as a finance professional spans over 20 years across a diverse range of businesses, from fine art to high-end retail to leisure and hospitality.
Prior to joining Eradigm, I was the Finance Director for a UK based hotel Group – my experience included managing all financial aspects of the difficulties associated with the Covid-19 pandemic, enabling the businesses to bounce back strongly when conditions eventually returned to normal.
What are your passions outside of work?
During the summer of 2021, I achieved a long-term goal to become a Qualified Personal Trainer. I enjoy all aspects of fitness and health and am regularly at the gym. Being from Cornwall, I also enjoy trail running on the coastal paths and open-water swimming, which I combine with beach-time whenever I’m able to.
Managers and Consultants
Louise rejoined Eradigm after serving as Head of Solutions at a clinical trial technology startup, where he helped develop and operationalize a digital platform to streamline end-to-end clinical trial delivery for biopharma sponsors. His work enabled faster, more reliable, and patient-centric trials, supporting the efficient development of new therapeutics.
At Eradigm, Louise has delivered strategic projects for global pharmaceutical clients across cardiovascular, renal, and metabolic disorders (CVRM), immunology, haematology-oncology, and rare diseases. His experience includes competitive intelligence, product launch readiness, market sequencing, value and access strategy, and integrated evidence planning. He is particularly skilled at aligning clinical development strategies with evolving market and access landscapes.
Louise holds an MPhil in Bioscience Enterprise from the University of Cambridge, where he worked with emerging life science companies on commercialization and product development. He also holds a BSc in Molecular Biology and Biotechnology and a Masters in Technology Management from the University of the Philippines, where he worked on the development of anti-pain drug candidates from conotoxin peptides.
In his free time, Louise enjoys tinkering with retro gaming consoles, creating digital artwork, and playing basketball.
Brynna joined Eradigm in July 2021 as an Associate Consultant, bringing extensive experience in biomedical research and a passion for global healthcare.
She holds a PhD in Cancer Biology from Barts Cancer Institute in London, part of Barts and the London School of Medicine and Dentistry. Her research was funded by the Biotechnology and Biological Sciences Research Council and focused on using technology to answer biological questions. There she was part of a multidisciplinary team of biologists and engineers, working to characterise and target a newly identified lung cancer driver mutation, and identify novel therapeutic strategies to treat it.
After completing her PhD, Brynna was awarded a grant to continue her research at Barts Cancer Institute as a postdoctoral researcher, and begin translating her research in the clinical sphere.
Prior to her academic studies, Brynna also worked in global health, where she developed tailored solutions to meet the needs of rural communities in Madagascar. There she led an initiative to improve public and environmental health through sustainable economic growth.
Outside of work, Brynna loves trying new and delicious food, as long as she doesn’t have to do the cooking. She is also an avid reader, loves taking on new knitting projects, and is learning to play the piano.
Focus Therapy Areas: Oncology (Solid Tumors & Hematology), Rare Disease, Cardiovascular
Specialist Expertise: Pricing and Market Access Strategy, Landscape Assessments, Market Insights
Education: BEng Mechanical Engineering, McGill University; MScEng Biomedical Engineering, Imperial College London
What is your focus at Eradigm?
At Eradigm, I bring a strong analytical background and understanding of global strategy, access, and pricing dynamics. My focus delivering targeted and impactful insights and recommendations to clients through high quality research and a collaborative engagement approach
Who do you work with?
I typically collaborate with global commercial and access teams, from both top 10-pharma and small to mid-size biotech companies.
What is your specialist expertise, and what types of projects do you work on?
My expertise lies in achieving developing strategic solutions to address business needs across broad therapeutic areas and geographical regions. I work across different project types delivering impactful market insights, commercial strategy recommendations, and understanding various pricing and reimbursement challenges in key geographies including the EU and Japan. Key capabilities include global primary research experience with payers and stakeholders, as well as secondaryresearch based landscape mapping in oncology, giving strategic support to clients across the product development lifecycle
What did you do before Eradigm?
Prior to Eradigm, I completed my MScEng degree in Biomedical Engineering completing a year-long research project working with a multidisciplinary team of doctors and engineers to build computational models that simulate and predict the development of congenital heart diseases in fetuses
What are your passions outside of work?
Outside of studies and work, I participated in several medical mission trips to rural and underserved communities in Haiti, Jamaica, India, and Brazil; experiences which have given me the motivation to make an impact on society through the biopharma industry. In my spare time, I love to travel, read and watch old movies
Barney joined Eradigm in January 2022 as an Associate Consultant, bringing an experience in bioscience research and a passion for improving global healthcare.
He holds a PhD in Interdisciplinary Bioscience from the University of Oxford, which formed part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Barney’s work focused on combining biocatalysts with continuous flow technology to improve the sustainable synthesis of pharmaceutical compounds. He was part of a team of chemists, biologists and engineers who worked to develop this biotechnology and successfully spin-out a company. In recognition of his work on this project, Barney was awarded a commendation in Enterprise and Innovation at the University of Oxford Bioscience Impact Awards.
As part of his PhD, Barney undertook a work placement at a large generics company. As part of the team, Barney applied the processes that he had developed in the academic laboratory to industrially relevant chemical transformations.
Barney completed his formative academic studies at the University of Warwick, graduating with an MChem in Chemistry with Professional Experience. His dissertation focused on performing enantioselective synthesis using novel organocatalysts. During his third year of study, Barney undertook a four-month placement at Monash University, Australia, which ignited his passion for academic research.
Outside of his work, Barney is a keen sportsman, who has played football at university level. He continues to enjoy many other sports, including cricket, golf, and squash, and finds pleasure in cooking, having a particular love for Indian and Italian cuisine. An inherited passion for music took hold during his younger years, growing up in Cornwall, at which time he travelled with local orchestras to perform in locations as far afield as San Francisco.
Nadeen joined Eradigm in April 2022 as an Associate Consultant, bringing to the team her extensive experience in genetic engineering and cancer research, and everlasting passion for the Life Sciences industry.
Nadeen holds a PhD in Molecular Biology & Biochemistry from the University of Westminster, where her work focused on the molecular characterisation a novel cancer driver gene in replication stress-induced genomic instability using CRISPR/Cas-based human cellular models, in collaboration with the Francis Crick Institute and the University of Zurich. During the pursuit of her doctorate, Nadeen was awarded research grants to support the clinical translation of genetically-engineered human cellular models to commercial products, in collaboration with renowned Life Science industries. Nadeen was also heavily involved in the co-design and mentorship of IBMS-accredited CRISPR/Cas-based workshops where she was consulted for her technical expertise on the use and applications of the cutting-edge technology.
Alongside her PhD studies, Nadeen acquired a professional development qualification in learning and teaching within the Higher Education Academy, U.K., and held a Visiting Lectureship position in Life Sciences at the University of Westminster for over three years. She also has experience in working as a Molecular Biologist at Health Services Laboratories (HSL) where she acquired extensive knowledge on the evolving clinical diagnostic landscape.
Outside of work, Nadeen is a curious soul who enjoys meeting new people and visiting new places. In her spare time, Nadeen enjoys salsa dancing as well as fitness through the practice of kickboxing, running and Pilates. She also enjoys reading on Science-related subjects and self-development, and whenever she gets the opportunity, she loves to travel and explore new cultures.
Oliver holds a PhD in Nutrition and Human Metabolism from the University of Birmingham, which was part of a Doctoral Training Programme funded by the Biotechnology and Biological Sciences Research Council. Oliver’s work focused on dairy nutrition, specifically trying to understand the metabolism of the milk sugar lactose in humans, to try to identify new applications for this low value, side stream product of the dairy industry. He has run human volunteer studies, in university laboratory and hospital settings across the country. He is interested in the intersection of nutrition and other modifiable lifestyle factors and healthcare, as well as life sciences and health more broadly.
Oliver also spent time working with the industrial partner of his PhD, a major European dairy ingredients company. He ran a market research project into consumer habits to identify gaps in product offerings and nominate new ingredients and products for development. This built on his previous experience in market research, throughout his undergraduate degree at the University of Exeter. Throughout his PhD, Oliver taught undergraduates extensively, from lecturing to running laboratory sessions. He particularly enjoyed the process of breaking down complex topics and explaining them to students. He is also an Associate Fellow of the Higher Education Academy.
Oliver is a passionate scuba diver, having recently completed his rescue diver qualification, he has dived extensively in Europe, Asia and Africa. Oliver is also a competitive powerlifter in his free time though has a keen interest in other strength sports. Throughout 2021 he volunteered with St John Ambulance to assist with the vaccine rollout, administering vaccines and helping to organise the day to day running vaccine centres.
Shreya joined Eradigm in April 2021 as an Associate Consultant. With a keen interest in novel therapeutic strategies, Shreya brings her experience in biomedical research and knowledge of the pharmaceutical industry to the team.
Shreya achieved her Master’s in Novel Therapies- Genes, Drugs and Stem Cells at Imperial College London where she took a multidisciplinary approach to understanding gene therapies, regenerative medicine, and the drug development process. For her master’s thesis, she worked on the optimization of synthetic mRNA for therapeutic use in airway epithelial cells. Prior to this, she completed her Bachelor’s degree in Genetics from the University of Sussex where she carried out research investigating the relationship between the structure and stability of DNA replication checkpoint proteins.
Alongside her academics, Shreya worked on an investment management start-up specializing in digital assets. This venture stimulated her ambition to apply her experience in life sciences in a more strategic business environment. She is also a huge believer in increasing the accessibility of education and has spent a year as a volunteer teacher, tutoring underprivileged kids in shelter homes in mathematics and science.
In her free time, Shreya enjoys exploring new restaurants, going to the cinema, and hiking. She summited Mt Kilimanjaro in 2018 to fundraise for clean water and sanitation and aims to summit Mt Everest by 2026.
Jessica holds a PhD in Cancer Epigenetic Epidemiology from Newcastle University, her project focused on DNA methylation as a potential mediator of early life exposures and the risk of childhood acute lymphoblastic leukaemia (ALL). During her PhD, she worked both in the laboratory and carried out computational analyses, collaborating with different faculties within Newcastle University and Bristol University. Throughout her PhD and post-doc position, Jessica taught molecular, genetic, epigenetic, and epidemiological modules on MSc courses at Newcastle University and supervised and assessed undergraduate/postgraduate students. Additionally, Jessica spent 3 years as a post-doctoral researcher at King’s College London, where her focus was in immune-oncology and computational biology, projects included exploring immune regulation and dysregulation in myeloproliferative neoplasms and myelodysplastic syndromes; and COVID-19 patient immune response to Baricitinib: can we predict immune dysregulation?
Since moving into life sciences consulting, Jessica has been part of, and led a variety of projects, mostly focused on oncology (both heme and solid tumours). Her experience includes data collection and interpretation, designing deliverables, leading client updates, deep-dives, attending conferences, delivering ad-hoc requests, and conducting comprehensive and robust primary and secondary market research. Experience in compiling competitive intelligence for novel therapeutics, including a thorough assessment of the commercial landscape, unmet needs, and market positioning. Additionally, Jessica has designed and run workshops to help clients understand competitors, pressure test assumptions, and gain deeper insight into the scientific aspects of their projects. Jessica has experience with healthcare systems in multiple geographies, including the US and EU.
Outside of work, Jessica loves to explore, whether it is a different country and culture or different parts of the UK, especially trekking through beautiful landscapes. Jessica is also a huge lover of music and spends a lot of time at gigs, events, or festivals.
Isaac joined Eradigm as an Associate Consultant in September 2022, bringing with him a breadth of experience working in pharmaceutical market research.
In his previous role, Isaac focused on conducting primary and secondary quantitative research, in order to provide actionable insights that would answer clients research needs and objectives. Isaac has experience utilising a wide array of complex research methodologies and working with some of the largest pharmaceutical companies around the world. It was during this time that he developed a real passion for global healthcare.
Isaac holds a Bsc in Psychology from the University of Manchester through which helped him gain extensive knowledge in areas such as behavioural psychology, cognitive neuroscience, quantitative research methodologies, and statistics and data analysis. For his dissertation he carried out his own research study, investigating the effects of loss aversion on visual extrapolation under risk.
Outside of work, Isaac is a big sports enthusiast with a particular passion for football, going to the gym and skiing. However Isaac is also big into his travel, music and cooking.
Senior Associate and Associate Consultants
Our senior team is supported by a range of Senior Associate and Associate Consultants with strong scientific backgrounds bringing breadth and depth to all of our client delivery engagements
Madina joined Eradigm as an Associate Consultant in July 2023, bringing her academic research experience and passion for Life Sciences industry to the team.
In her previous job Madina was conducting research and analysis of fine chemicals industry in the UK, working alongside world-class academics at Imperial College. She holds a Master’s degree with Distinction in International Health Management from Imperial College London, which provided her with commercial awareness and practical knowledge in health economics, business and marketing for healthcare and pharmaceutical companies.
Prior to this, Madina graduated from University College London with BSc Pharmacology, where she developed extensive knowledge and expertise in biomedicine and drugs. Her dissertation was focused on researching potential physiological targets for treatment of endothelial dysfunction, a type of non-obstructive coronary artery disease. Madina also completed an internship in consulting within sustainability, which encouraged her to pursue her career in consulting industry.
In her free time, Madina enjoys playing tennis, singing, exploring museums and hanging out with friends. She is also passionate about food and different cuisines, so cooking and baking provide her with space for creativity.
Nephelie joined Eradigm in November 2023 as an Associate Consultant.
Nephelie holds a MEng in Chemical Engineering, with her dissertation research involving the fabrication of tissue engineering scaffolds for skin regeneration. She has additionally completed an MSc (Honours) in Nanotechnology and Regenerative Medicine from University College London (UCL), where she earned a spot on the dean’s list. Her research focused on exploring the role of borosilicate bioactive glasses in bone regeneration.
She has also pursued an MBA degree, enhancing her understanding and effectiveness in addressing complex healthcare challenges, conducting extensive pharmaceutical market analyses, and delivering strategic advice to pharmaceutical companies.
Prior to joining Eradigm, she worked as a Consultant at FTI Consulting, where she coordinated the company’s Data Analysis Initiative, gaining experience in implementing coding solutions for automating standard analysis methods. She has also acted as a Product Marketing Manager at a pioneering start-up company. Her tasks included the development of the go-to-Market strategy of the company, managing online marketing efforts, and closely monitoring the market landscape to gain insights on the current artificial skin therapies.
Outside of work, Nephelie stays active with yoga and cycling and is always eager to try out different fitness classes. She’s all about exploring the post-pandemic London scene, keeping an eye out for concerts, gigs, and dancing events”
Tiya joined Eradigm in July 2023 as an Associate Consultant, bringing to the team her passion for advancing healthcare research and prior experiences working in PR, medical communications, and digital health start-ups.
Previously, Tiya was a PR consultant managing several pharmaceutical clients and various projects, spanning therapeutic areas including neurology, immunology, orthopaedics, dermatology, and women’s health. Tiya was involved in advising clients with their communications strategy during key congresses, on data communications and competitive insights, developing high-quality HCP and patient materials, and managing relationships with patient advocacy groups and multiple external stakeholders.
Tiya holds a BSc in Biological Sciences from the University of Leicester, where she studied Neuroscience and focused her dissertation and research interests in maternal health and child neurodevelopment. Tiya studied for her MSc at University College London (UCL), in Bioscience Entrepreneurship, where she developed her expertise in the intersection between life sciences and research commercialisation. During her post-graduate studies, Tiya worked at digital health start-ups which intend to disrupt and transform standard healthcare and medicine, through innovations in digital technology. At Syrona Health, spinout FemTech company from University of Cambridge, Tiya developed an in-app digital tool for personalised contraception with a focus on limiting side effects. Tiya was also part of the 2021 Entrepreneur In Residence cohort for idea incubation in European healthcare, with SanusX UNIQA, a leading insurance provider in CEE.
From her experiences in medical communications, working at MedTech startups, and her studies, Shakitiya hopes to continue expanding her knowledge in the fields of entrepreneurship, science communication, healthcare and research.
Outside of work, Tiya likes to keep active with weight-lifting, salsa-dancing, Muay Thai, and swimming. Passionate about exploring new cultures, Tiya enjoys travelling around the world, meeting new people, and experiencing local cuisines.
Estela joined Eradigm in September 2023 as an Associate Consultant, bringing her enthusiasm for aiding healthcare companies in advancing and commercializing therapies, coupled with her professional and academic achievements in the life sciences.
Previously, Estela worked at GLG, supporting multiple clients across the pharmaceutical and diagnostic industries to connect with key experts and stakeholders across the product lifecycle. Here, Estela built commercial and industry knowledge, by working on projects across multiple therapeutic areas and stages of development.
Estela holds a BSc in Biomedical Sciences from University College London, which included a neuroscience research project, specifically on the molecular programming of MGE-derived cortical interneurons. Estela also holds an MSc in Genes, Drugs, and Stem Cells – Novel Therapies from Imperial College London, where she explored the cell and gene therapy landscape, and conducted research on the role of key miRNAs in ischaemic heart disease and diabetes.
From her experience at GLG and university degrees, Estela hopes to get one step closer to supporting healthcare clients with product commercialisation, and helping patients get access to treatments.
In her free time, Estela enjoys sewing, reading, listening to true crime podcasts, swimming, and going to the gym.
Paula joined Eradigm in May 2022 as an Associate Consultant. With a keen interest in personalised medicine and novel therapies, Paula brings her experience in biomedical research to the team.
Paula holds an MSc in Engineering for Biomedicine from Imperial College London, where she researched new materials approaches for the detection and treatment of cancer. Prior to that, Paula completed her BSc in Human Biology from Pompeu Fabra University in Spain, where she took a multidisciplinary approach to learn about biomedical sciences and did her bachelor’s thesis on secretion pathways altered by colon cancer. During her BSc, Paula did an exchange programme at the Amsterdam University College in The Netherlands where she took global healthcare courses and developed her language skills.
Alongside her education, Paula spent time doing internships at the University of California San Diego, in the US, and at Sant Pau Hospital, in Spain, where she explored clinical and genetic approaches to diseases of the airways. These experiences in different cultures grew her ambition to use her life sciences knowledge for application approaches in an industry environment and led Paula to work on innovation strategies in between her studies.
Paula also believes in bringing scientific knowledge and education closer to those outside the science and medical communities and has worked and volunteered in Medical Information and Tutoring projects to increase accessibility in these areas.
Outside of work, Paula enjoys travelling, cooking, and music. She has a keen interest in combining these three hobbies and finding new ways of sharing them with other people.
Julia is originally from sunny Spain, now calling London home. She joined Eradigm in September 2025 as a Senior Associate Consultant, bringing with her a mix of scientific curiosity and strategic thinking.
Her academic path started with an MSc in Physics, followed by her PhD in Molecular biology that focused on exploring the mechanical and adhesive interactions that coordinate tissue morphogenesis during Drosophila embryonic development. She subsequently completed a postdoctoral fellowship in Biophysics at University College London, investigating the multiscale biomechanics of tissue rupture in epithelial cell models, culminating in a Nature Materials publication (2024).
Before joining Eradigm, Julia worked at L.E.K. Consulting as a Life Sciences Specialist, advising biotech and pharma clients on everything from R&D strategy to market entry. She loves connecting the dots between science and business, and she thrive ls on solving complex problems with creative, evidence-based solutions.
Outside of work, Julia is a big fan of baking spongy cakes with olive oil (although she still loves buttery French madeleines), swimming, reading books with pretty covers, discovering new music and podcasts, and going to live gigs whenever she can.
Suruchi joined Eradigm as an Associate Consultant in September 2024, driven by her passion for supporting healthcare innovation and bringing new therapies to market.
With a PhD in Biochemistry from the Max Planck Institute of Molecular Physiology, she explored the intricacies of cell cycle regulation, focusing on how cells ensure accurate chromosome separation by accelerating the formation of the Mitotic Checkpoint Complex (MCC). Her research employed an in vitro setup to recreate the cellular machinery, revealing how specific proteins expedite MCC formation at the kinetochores, ensuring efficient and error-free cell division.
Combining her scientific expertise with practical experience, she immersed herself in London’s vibrant startup ecosystem by joining the Innovation Forum as a Programme Coordinator. In this role, she fostered connections among a network of over 10,000 investors, academics, and startups, and coordinated events focused on the latest healthcare innovations. To deepen her understanding of healthcare trends and the challenges faced by entrepreneurs, she also joined the Science Entrepreneur Club as a Science Writer, engaging with founders in life sciences to uncover the unique aspects of their startups and showcase their journeys.
Outside of work, she enjoys winding down with a good book and a great cup of coffee and is committed to building a habit of practicing yoga and going to the gym.
Diana joined Eradigm in January 2025 as an Associate Consultant, driven by her passion for bringing innovative therapies to the market. With a strong scientific background and diverse business experience, she is skilled at bridging the gap between science and the market, identifying opportunities, assessing risks, and providing market access insights.
Before joining Eradigm, Diana worked as a Venture Capital Fellow at the London Venture Capital Network, gaining expertise in the life sciences startup ecosystem. She evaluated startups through scientific and commercial due diligence and provided competitive analysis to support investment decisions, all while building professional relationships at the partner level. Diana has also worked as a Consultancy Project Manager at London Healthcare Insights, leading market and health economic research on health technologies in UK retail pharmacies and virtual wards, while advising clients on regulatory pathways. Her extensive research background includes a role as a Research Assistant at University College London, where she collaborated with Dr Maryam Parhizkar on tissue-engineered vascular grafts. Diana contributed to refining formulations through primary and secondary research, co-authored research findings with PhD students, and supervised an MSc dissertation on drug-loaded vascular grafts.
Diana holds a BSc in Clinical and Community Pharmacy from Bandung Institute of Technology and is a licensed pharmacist. During her placements, Diana was exposed to product lifecycle management, pricing, and reimbursement strategies. Her interest in the business side of life sciences led her to pursue an MSc in Pharmaceutical Formulation and Entrepreneurship at University College London, graduating with distinction and earning a place on the Dean’s List. There, she gained hands-on experience in nanoformulation for rare diseases, startup due diligence, financial modelling, and evaluating the commercial potential of healthcare innovations. For her dissertations, Diana developed a tissue-engineered vascular graft for hemodialysis and assessed its commercial viability.
Outside of work, Diana enjoys staying active with lagree megaformer, reformer pilates, and boxing. She is also a big fan of matcha and loves weekend bakery runs with her friends.
Antonio joined Eradigm in January 2025 as an Associate Consultant. He holds a PhD in Molecular Immunology from UCL, where his research focused on the impact of IL-10 family cytokines and microbial metabolites on intestinal permeability. His work included in vitro assessments of epithelial permeability, proliferation, apoptosis, and wound healing, as well as analysing intestinal permeability and cytokine profiles in patients undergoing haematopoietic stem cell transplantation compared to healthy controls.
Prior to his PhD, Antonio contributed to the optimisation of a UCL-patented lentiviral vector for clinical applications as a research assistant. He also gained significant experience as a pharmacist, managing multiple community pharmacies and clinics, which honed his leadership skills and business acumen.
Outside of work, Antonio enjoys practising Brazilian Jiu-Jitsu, exploring new restaurants and theatres and enjoys fishing whenever the opportunity arises.
Samuel joined Eradigm in January 2025 as an Associate Consultant, bringing experience in early stage life sciences research, venture capital investment, and entrepreneurship.
Following a Physics BSc at the University of Bath, where his research focused on computational neuron models, Samuel was awarded a distinction for his MSc in Biological Physics at UCL. There, he built a computational model of cancer mutations whilst simultaneously working as a research assistant at a pharmaceutical startup and founding a student-led think tank centred on bioethics and medical law.
Most recently, Samuel completed his PhD at the world leading neutron source, L’Institut Laue Langevin, in collaboration with AstraZeneca and the University of Manchester. His research focused on the nucleic acid delivery vehicle used in the Pfizer/Moderna COVID-19 vaccine. During the final year of his PhD, Samuel gained valuable insights as a Venture Associate at the AIxBio venture capital fund, Next Sequence, where he evaluated startups and technologies in the space-based life sciences vertical.
Outside of work, Samuel enjoys spending time reading literature with a philosophical theme, swimming, exploring new cafés, and going to art exhibitions. His favourite travel story is his three month solo-backpacking trip across China.
Sarah joined Eradigm in September 2024 as an Associate Consultant, driven by her passion for supporting healthcare and pharmaceutical companies in strategising, advancing, and commercialising innovative therapies. With a strong academic foundation and valuable professional experience, she is excited to contribute to Eradigm’s mission and thrive in her consulting career.
Before joining Eradigm, Sarah worked at Guidepoint, where she supported clients across the pharmaceutical and healthcare sectors by connecting them with key industry experts. Here she developed broad commercial and industry insights, as she collaborated with a diverse range of clients in the Healthcare sector. Prior to this, Sarah worked in recruitment as a Talent associate and advanced quickly to Senior Talent Associate, specialising in executive-level recruitment. She collaborated closely with global directors, driving recruitment strategies that exceeded organisational goals.
Sarah holds a BSc in Medical Physiology from the University of Leicester, where she graduated with a First Class Honours. Her dissertation focused on the bioethical analysis of egg freezing in the UK, for which she earned a First Class. Additionally, she worked on a project mapping the complex progression of cancer, exploring aspects such as monoclonal origin and tumour heterogeneity, for which she was awarded top performance in the module. Sarah has just completed her MSc in Biotech and Pharmaceutical Management at University College London (UCL), where she was awarded two prestigious scholarships: the UCL East London Scholarship and the Global Business School for Health Women Healthcare Leaders Scholarship. Her research project focused on evaluating factors affecting medication adherence to anti-diabetic medication among patients in Nigeria.
Additionally, during her time at UCL, Sarah collaborated with a team on a business project to develop an innovative hydrogel wound dressing, designed with unique properties to improve the treatment of diabetic foot ulcers. Together, the team crafted a detailed business proposal highlighting the product’s commercial viability and market potential, further demonstrating Sarah’s ability to blend scientific expertise with strategic business acumen.
Outside of work Sarah enjoys travelling, eating out, reformer pilates, Sunday church services, and unwinding by watching the real housewives!
Auxtine joined Eradigm in September 2024 as an Associate Consultant. She holds a PhD in Precision Oncology from University College London (UCL).
Her work involved bioengineering 3D in vitro tumour models, which served as testing platforms for mechano-based cancer therapies. Auxtine is well published, with four first-author publications in high-impact, peer-reviewed journals, as well additional second author publications. During her time at UCL, she won multiple awards, including a nomination to join annual Nobel Laureates gathering, as an outstanding young scientist. She also holds a MEng and a BEng in Biomedical Engineering from Imperial College London.
Prior to joining Eradigm, she worked as a senior scientist at an investor-backed biotech start-up, where she was in charge of building a regenerative medicine programme using novel adult multi-potent stem cells. There she was also involved in commercial development, growth strategy, patent applications, and fundraising.
Outside of work, Auxtine enjoys reformer pilates classes, reading, walks in the parks, and trying out new coffee shops, wine bars and restaurants with friends.
Juan joined Eradigm in July 2025 as an Associate Consultant, bringing experience in early-stage life sciences research and development.
Juan holds a PhD in Chemical Engineering at Imperial College London, where his research focused on the design of live biotherapeutics. There, he also completed an MRes working on regenerative medicine, and previously he did an undergraduate degree from Universidad Carlos III de Madrid in Biomedical Engineering. Alongside his academic training, Juan collaborated with venture capital firms to explore and evaluate translational technologies and worked with two therapeutic discovery Imperial spinouts on business development and go-to-market strategy.
Outside of work, Juan enjoys playing tennis, running, and strength training. He also loves discovering new food spots around London and spending time outdoors.
Maria has a background spanning pharmaceutical operations, translational research, and life sciences innovation. She holds an MSc in Molecular Biology and Pathology of Viruses from Imperial College London and has worked across both academic and industry settings, with a particular focus on cell and gene therapy, immunology, and early-stage biotech. Throughout her career, she has been driven by one goal: to help accelerate the way therapies are delivered to patients.
Before moving into consulting, Maria worked at the interface of science and innovation in oncology and advanced therapies. She contributed to projects involving market research and scientific deep dives, including supporting a precision oncology diagnostics startup with their market strategy, and helping a biotech company shape its manufacturing approach for a novel autologous cell therapy.
Earlier in her career, Maria was part of the Translational Immuno-dermatology group at the University of Zurich, where she helped establish a molecular lab and led biomarker-focused projects using multi-omics techniques. This work contributed to a systematic review on treatment trends in autoimmune skin diseases.
She also worked at Novartis within Cell & Gene Therapy Technical Operations, where she supported commercial manufacturing, process optimisation, and cross-functional project coordination, contributing to improvements in productivity and operational efficiency.
Outside of work, Maria enjoys going to the gym, travelling, and spending time with friends over good food. She’s also a podcast enthusiast and loves dancing—especially Latin and traditional Greek dances.
Christiana joined Eradigm in August 2025, bringing a unique blend of knowledge and expertise in biomedical research. She holds a PhD in Hematology and Infectious Disease from Imperial College London, funded by the Wellcome Trust and MSc Genetics of Human disease from UCL. During her PhD project she identified a subset of blood stem cells that resist malaria infection and characterised their localisation within the bone marrow.
Having spent 10 years in an academic setting, her scientific work extends beyond hematology. Previously she led multi-phase research project at Francis Crick Institute, specifically in the area of retro-immunology, where she worked to identify retro-transposable elements in leukaemia patients treated with chemotherapy. Alongside that, she worked to identify biomarkers in skin melanoma cell lines.
Christiana is motivated by the opportunity to apply her scientific insight to strategic healthcare decisions that improve patient outcomes. Outside of work, she enjoys DIYs, exploring nature, gym, beach volleyball, reading, and cooking
Ruby holds a PhD in Biomedical Engineering, specialising in neuroscience, from the University of Reading, and brings a strong combination of academic, pharmaceutical, and analytical experience. With a deep passion for applying scientific expertise to address complex challenges in the life sciences industry, she is dedicated to driving innovation and improving healthcare outcomes.
During her doctoral studies, Ruby investigated the effects of hormones on stroke using advanced electrophysiology techniques, such as multi-electrode arrays (MEA), along with a broad range of biological and statistical methods. By integrating electrophysiology with molecular and biochemical assays, her research aimed to uncover mechanisms that could inform the development of new stroke therapies. This work contributed to interdisciplinary research initiatives focused on enhancing patient outcomes through the fusion of engineering and neuroscience.
In addition to academic research, Ruby has worked in pharmaceutical manufacturing, compounding bespoke medications in laboratory settings for patients with diverse medical conditions.
A committed advocate for women in STEM, Ruby has led workshops in schools, facilitated STEM clubs to inspire young learners, and tutored students in science. She is also an active supporter of the Alzheimer’s Society and has participated in fundraising initiatives such as hiking Ben Nevis to raise awareness and support dementia research.
Outside of her professional pursuits, Ruby enjoys swimming, experimenting with new recipes, and reading. With a keen interest in philosophy, she is particularly fascinated by the power of the mind and its influence on human potential and wellbeing.
Luke joined Eradigm in August 2025 as an Associate Consultant, bringing a focus on commercial strategy in life sciences. Prior to this, he was an Analyst at Complement Therapeutics, where he supported data analysis for a natural history study and competitive intelligence in AAV gene therapy and geographic atrophy. He has also worked as an Analyst at Northwick Partners, contributing to projects across ophthalmology and oncology.
Luke completed an MSc in Bioscience Innovation and Enterprise at University College London (UCL), a programme that combines scientific research with business strategy, entrepreneurship, and healthcare innovation. Highlights from his master’s include a research and business case project on the feasibility of AI-enhanced retinal scans as a non-invasive test for amyloid positivity in early Alzheimer’s disease and conducting due diligence on a drug discovery biotech, including cap table analysis to inform an investment decision. As Client Projects Executive for the UCL Consulting Society, he sourced and managed consultancy projects for life science startups delivering work across product and pricing strategy, fundraising and market intelligence. Throughout his time at university, Luke also held roles as Social Secretary of a MedTech and Biopharma Society and as a VC Analyst at Innovis VC, sourcing early-stage deep tech start-ups for partner venture capital firms.
He is particularly interested in the development and commercialisation of advanced therapies, especially in the fields of cell and gene therapy. Outside of work, he enjoys festivals, swimming and training in Muay Thai.
Core Services Team
Originally from Poland, Natalia built her career in operations after moving to the UK, gaining experience in various roles, from supervising a fashion brand to managing office spaces, before stepping into her leadership role at Eradigm.
Natalia joined Eradigm in 2023 and leads operations across Finance, HR, and Partner support. She plays a key role in ensuring the smooth running of day-to-day business functions while continuously identifying opportunities to improve efficiency and maximize return on investment. As a central support to the wider team of consultants, she streamlines processes and enhances operational effectiveness.
Outside of work, she enjoys drawing and spending time with her Cocker Spaniel puppy, Guinness, who has quickly become an honorary member of the Eradigm team.
My focus here at Eradigm is to contribute to the success of the business and, of course, it’s employees. As well as this, being a key point of contact, problem solving and creating a thriving working environment for all is what I aim to achieve.
Who do I work with?
I work side by side with the HR Director, the Operations Team and the Finance Team.
What did I do before Eradigm?
My career in HR started in 2022 after graduating with a Psychology degree from Coventry University, when I joined a data consulting firm as HR Assistant.
In my short career so far, I’m lucky to have been exposed to many processes such as training, benefits, probation, improving company culture and employment policies and procedures. Having been half of the HR team since I started my career, I’ve adopted an ‘all hands-on deck’ personality, enabling me to be everywhere at once, whilst producing high quality and accurate work.
What are your passions outside of work?
Recently, I went on a solo trip to Dubai for 10 days and it’s safe to say that won’t be my last! My aim is to solo-travel at least once a year. Additionally, I love hairdressing and I have done since I was young. Lastly, I love serving in my church!
Education:
BSc in Chemistry from University of Birmingham.
Management Accounting and Reporting
What is your focus at Eradigm?
My main focus at Eradigm is to streamline the financial processes to cope with the tremendous growth the company has experienced. I am also responsible for month-to-month cashflow, accounts payable and invoice scheduling.
Who do you work with?
I work closely with the financial controller of Eradigm to help maintain the monthly management accounts and reports for the partners.
What is your specialist expertise, and what types of projects do you work on?
My main expertise is that I am analytically minded and as a result, most of my projects will involve reconciliations and problem solving and ensuring all financial data is accurate. I have also had previous experience with systematic reviews to improve the efficiency of the finance team, my attention to detail is crucial for my project involvement.
What did you do before Eradigm?
Prior to working at Eradigm, I have had experience in the fintech industry, as well as the fine art/auction industry. All my previous roles have provided me with excellent financial acumen and skills.
What are your passions outside of work?
I am actively studying for my CIMA accountancy exams. I am a huge sports fan and I am always looking for a new and exciting sport to get involved in. I am also passionate about food and pub quizzes.
Education:
After completing my A-Levels, I went straight into employment. My career in a finance-related environment started 4 years ago, where I trained as a Bookkeeper and Payroll Administrator in an Accounting Firm. Throughout my career, I studied and gained my Level 2 AAT Foundation Certificate in Bookkeeping.
What is your focus at Eradigm?
My focus at Eradigm is to learn about the financial processes of the company and provide finance support. Throughout the years, I have developed a very keen interested in finance and I am very much looking forward to developing my career within this department.
What did you do before Eradigm?
Prior to joining at Eradigm, I was working as a counter assistance in a pharmacy for three to four years. When I decided if it was not for me, I left the job and started working for an accountant firm based in Coulsdon. Then I left the firm to focus more on payroll, where I worked sorely as a payroll administrator.
What are your passions outside of work?
My passion outside of work is spending my time with my loved ones. I also enjoy learning new subjects such as different philosophies, writing and art! As boring as it sounds, I am the type of person that can spend hours in a museum. But also enjoy more “fiery” activities such as traveling, yoga, paintballing & playing my PlayStation (If that counts)…
Our Values
Values are what make a business successful, unique, long-lasting – and what allows Eradigm to attract outstanding professionals to be a part of our team.
What Eradigm stands for as a business covers many areas. At our core, we uphold the principles of integrity, innovation, and a relentless pursuit of excellence. These fundamentals guide us in delivering meaningful solutions and fostering sustainable growth in all that we do. Take a look below at how our values shape our work:
Drive Excellence
Embracing challenges is fundamental to our corporate ethos, driving us to revolutionize, adapt, and achieve excellence in every endeavor we pursue
Nature Partnerships
Our corporate strength lies in cultivating enduring relationships with clients, fostering collaboration, trust, and mutual success at every level
Celebrate Diversity
At Eradigm, we recognize that diversity of experience, thought and background, enriches our culture and our services, bringing drive innovation and transformative engagements
Leave a Legacy
Dedicated to leaving a profound legacy in the life sciences sector, contributing to pioneering innovations that shape the future of healthcare and improve the well-being of patients
Contact information
Fill in the contact form and a member of your team will get back to you
info@eradigm.com
Eradigm Consulting
Work.Life
6-7 St Cross St,
London, EC1N 8UB
